Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1668785 | 0.86 | FDPS (0.39) | FDPSPDE3A | |
| SCHEMBL14217571 | 0.84 | — | — | |
| SCHEMBL10073144 | 0.83 | FDPS (0.42) | LMNAFDPSPDE3A | |
| SCHEMBL12848975 | 0.80 | — | — | |
| SCHEMBL15492658 | 0.76 | — | — | |
| SCHEMBL13334580 | 0.74 | — | — | |
| SCHEMBL8259996 | 0.73 | FDPS (0.32) | FDPSPDE3A | |
| SCHEMBL14942976 | 0.73 | ADH1B (0.32) | — | |
| SCHEMBL16327574 | 0.73 | — | — | |
| SCHEMBL15492659 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170164642-A1 | Preservative System For Acidic Beverages Based On Sequestrants | PEPSICO, INC. | 2017-06-15 | — | — | US | disclosed |
| US-9560871-B2 | Preservative system for acidic beverages based on sequestrants | PEPSICO, INC. (US) | 2017-02-07 | — | — | US | disclosed |
| WO-2012054807-A2 | VACCINES COMPRISING BISPHOSPHONATE AND METHODS OF USE THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-04-26 | — | — | WO | disclosed |
| US-7902310-B2 | Use as additives for inorganic binding agent suspensions based on cement, lime, gypsum and anhydrite; improve processing and setting processes of building materials produced with these additives by making possible earlier and higher resistances to pressure | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2011-03-08 | — | — | US | disclosed |
| US-20100166917-A1 | Preservative System For Acidic Beverages Based On Sequestrants | PEPSICO, INC. (US) | 2010-07-01 | — | — | US | disclosed |
| US-20080317834-A1 | Compounds and methods for modulating cerebral amyloid angiopathy | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2008-12-25 | — | — | US | disclosed |
| US-20080220037-A1 | Biphosphonic Compounds For Preventing Or Limiting Fixing Of Macromolecules, Microorganisms And Biofilm On Solid, In Particular Metal Or Mineral Surfaces | SURFACTIS TECHNOLOGIES (FR) | 2008-09-11 | — | — | US | disclosed |
| US-20080125520-A1 | Copolymers Base on Phosphorous-Containing Monomers, Methods for the Production Thereof and Their Use | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2008-05-29 | — | — | US | disclosed |
| US-20070078082-A1 | Methods and compositions to treat glycosaminoglycan-associated molecular interactions | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080220037-A1 | Biphosphonic Compounds For Preventing Or Limiting Fixing Of Macromolecules, Microorganisms And Biofilm On Solid, In Particular Metal Or Mineral Surfaces | BPGM, FIBP, SOST | LMNA 4002/4885ADRB3 4883/4885FDPS 65/4885 |
| US-20080317834-A1 | Compounds and methods for modulating cerebral amyloid angiopathy | APP, PYGB, MAPT | LMNA 1103/4885ADRB3 576/4885FDPS 1920/4885 |
| US-20070078082-A1 | Methods and compositions to treat glycosaminoglycan-associated molecular interactions | HPSE, CD44, CSGALNACT1 | LMNA 2106/4885ADRB3 4557/4885FDPS 4229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.